<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
<channel>
<title>The Moldovan Medical Journal, Vol. 61, No 3, October 2018</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/17898</link>
<description/>
<pubDate>Fri, 10 Apr 2026 23:08:14 GMT</pubDate>
<dc:date>2026-04-10T23:08:14Z</dc:date>
<item>
<title>The Moldovan Medical Journal. October 2018, Vol. 61, No 3</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/16267</link>
<description>The Moldovan Medical Journal. October 2018, Vol. 61, No 3
The Moldovan Medical Journal is an international scientific double-blind peer-reviewed periodical edition, 6 per year, of the Scientific Medical Association of the Republic of Moldova designed for specialists in the areas of medicine, dentistry, pharmacy, social medicine, and public health. From its debut, the journal has striven to support the interests of Moldovan medicine concerning the new concepts of its development. The Editorial Board warmly welcomes both the readers of and the authors of the journal, all those who are enthusiastic about searching for new and more effective ways of solving numerous medical problems. We hope that those who want to make their contribution to the science of medicine will find our journal helpful and encouraging.
Fondatori: Ministerul Sănătăţii al Republicii Moldova, Universitatea de Stat de Medicină şi Farmacie “Nicolae Testemiţanu”
</description>
<pubDate>Mon, 01 Jan 2018 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://repository.usmf.md:80/xmlui/handle/20.500.12710/16267</guid>
<dc:date>2018-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>The monograph “The operated ear disease”, the author Sergiu Vetricean</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/15289</link>
<description>The monograph “The operated ear disease”, the author Sergiu Vetricean
Popa, Vladimir
Department of Otorhinolaryngology,&#13;
Nicolae Testemitsanu State University of Medicine and&#13;
Pharmacy Chisinau, the Republic of Moldova
</description>
<pubDate>Mon, 01 Jan 2018 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://repository.usmf.md:80/xmlui/handle/20.500.12710/15289</guid>
<dc:date>2018-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Victor Vovc 70-year anniversary</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/13654</link>
<description>Victor Vovc 70-year anniversary
Ababii, Ion
Nicolae Testemitsanu State University of Medicine and Pharmacy&#13;
Chisinau, the Republic of Moldova
</description>
<pubDate>Mon, 01 Jan 2018 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://repository.usmf.md:80/xmlui/handle/20.500.12710/13654</guid>
<dc:date>2018-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Coronary revascularization in patients with ischemic left ventricular dysfunction</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/1219</link>
<description>Coronary revascularization in patients with ischemic left ventricular dysfunction
Yepanchintseva, Оlga; Ivanyuk, Natalia; Borkhalenko, Yulia; Zharinov, Оleg; Тоdurov, Borys
Background: Coronary artery disease (CAD) dominates in the contemporary world among the causes of left ventricular dysfunction (LVD). Prognosis&#13;
of survival and the course of heart failure (HF) are worse in patients with CAD than in many kinds of non-ischemic cardiomyopathy. Development of&#13;
cardiac surgery technologies and formation of the relevant evidence base have significantly expanded the role of revascularization in patients with CAD&#13;
and reduced left ventricular ejection fraction (LVEF). The possibility and expediency of coronary artery bypass grafting (CABG) for improving left&#13;
ventricular ejection fraction (LVEF), clinical course of HF and survival are evidence-based. Stenting is less effective than coronary artery bypass grafting&#13;
(CABG) regarding the influence on primary endpoints but improves the quality of life of patients with CAD and ischemic LVD.&#13;
Conclusions: In patients with ischemic LVD, surgical revascularization can ensure an improvement in the pumping function of the heart, provided&#13;
there is a sufficient amount of viable myocardium. From the standpoint of evidence-based medicine, the effectiveness of CABG surgery in patients with&#13;
multivessel lesion of the coronary bed and LVD has been proven for correction LVEF, improvement of the course of the disease and prediction of survival&#13;
compared with the optimal drug therapy. Percutaneous intervention is inferior to surgical revascularization in terms of its effect on endpoints, but it can&#13;
make an improvement in the quality of life of patients with ischemic LVD. Evaluation of myocardial viability may be of additional importance for the&#13;
decision on the feasibility of CABG in the presence of multivessel coronary artery disease combined with a sharp decrease in LVEF.
Heart Institute, Shupyk National Medical Academy of Postgraduate Education, Kiev, Ukraine
</description>
<pubDate>Mon, 01 Jan 2018 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://repository.usmf.md:80/xmlui/handle/20.500.12710/1219</guid>
<dc:date>2018-01-01T00:00:00Z</dc:date>
</item>
</channel>
</rss>
